Shanghai Fudan Zhangjiang Bio Pharmaceutical Co (DE:FDY) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. has enacted new governance rules to enhance the management and efficiency of its Board of Directors, ensuring decisions align with shareholder interests and legal regulations. The Board, comprising seven to eleven directors, including executive, non-executive, and independent members, must adhere to these regulations, which are designed to standardize procedures and reinforce the company’s organizational structure. These changes are aimed at improving the company’s strategic decision-making and operational oversight in compliance with Chinese law and stock exchange requirements.
For further insights into DE:FDY stock, check out TipRanks’ Stock Analysis page.
